Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

被引：1
|
作者：
Morris, Van K.
Yothers, Greg
Kopetz, Scott
Jacobs, Samuel A.
Lucas, Peter C.
Iqbal, Atif
Boland, Patrick M.
Deming, Dustin A.
Scott, Aaron James
Lim, Howard John
Wolmark, Norman
George, Thomas J.
机构：
[1] NRG Oncol, Houston, TX USA
[2] UT MD Anderson Canc Ctr, Houston, TX USA
[3] NRG Oncol, Pittsburgh, PA USA
[4] Univ Pittsburgh, Pittsburgh, PA USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[7] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[8] Baylor Coll Med, Houston, TX 77030 USA
[9] Rutgers Canc Inst New Jersey & Alliance, New Brunswich, NJ USA
[10] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[11] ECOG ACRIN, Madison, WI USA
[12] Univ Arizona, Ctr Canc, Tucson, AZ USA
[13] SWOG, Tucson, AZ USA
[14] British Columbia Canc Vancouver, Vancouver, BC, Canada
[15] CCTG Cochair, Vancouver, BC, Canada
[16] NRG Oncol, Gainesville, FL USA
[17] Univ Florida, Hlth Canc Ctr, Gainesville, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4121
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study
    Babaei, Masoud
    Balavarca, Yesilda
    Jansen, Lina
    Lemmens, Valery
    van Erning, Felice N.
    van Eycken, Liesbet
    Vaes, Evelien
    Sjovall, Annika
    Glimelius, Bengt
    Ulrich, Cornelia M.
    Schrotz-King, Petra
    Brenner, Hermann
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (07) : 1480 - 1489
  • [42] CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial
    Rothe, Francoise
    Maetens, Marion
    Rouas, Ghizlane
    Paesmans, Marianne
    Van den Eynde, Marc
    Van Laethem, Jean-Luc
    Vergauwe, Philippe
    Deboever, Guido
    Bareche, Yacine
    Vandeputte, Caroline
    Ignatiadis, Michail
    Hendlisz, Alain
    BMC CANCER, 2019, 19 (1)
  • [43] CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial
    Françoise Rothé
    Marion Maetens
    Ghizlane Rouas
    Marianne Paesmans
    Marc Van den Eynde
    Jean-Luc Van Laethem
    Philippe Vergauwe
    Guido Deboever
    Yacine Bareche
    Caroline Vandeputte
    Michail Ignatiadis
    Alain Hendlisz
    BMC Cancer, 19
  • [44] Patterns of Referral for Adjuvant Chemotherapy for Stage II and III Colon Cancer: A Population-Based Study
    Chandhoke, Gursimran
    Wei, Xuejiao
    Nanji, Sulaiman
    Biagi, James
    Peng, Yingwei
    Krzyzanowska, Monika
    Mackillop, William J.
    Booth, Christopher M.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (08) : 2529 - 2538
  • [45] Patterns of Referral for Adjuvant Chemotherapy for Stage II and III Colon Cancer: A Population-Based Study
    Gursimran Chandhoke
    Xuejiao Wei
    Sulaiman Nanji
    James Biagi
    Yingwei Peng
    Monika Krzyzanowska
    William J. Mackillop
    Christopher M. Booth
    Annals of Surgical Oncology, 2016, 23 : 2529 - 2538
  • [46] A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer
    W Schippinger
    H Samonigg
    R Schaberl-Moser
    R Greil
    R Thödtmann
    J Tschmelitsch
    M Jagoditsch
    G G Steger
    R Jakesz
    F Herbst
    F Hofbauer
    H Rabl
    P Wohlmuth
    M Gnant
    J Thaler
    British Journal of Cancer, 2007, 97 : 1021 - 1027
  • [47] A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer
    Schippinger, W.
    Samonigg, H.
    Schaberl-Moser, R.
    Greil, R.
    Thoedtmann, R.
    Tschmelitsch, J.
    Jagoditsch, M.
    Steger, G. G.
    Jakesz, R.
    Herbst, F.
    Hofbauer, F.
    Rabl, H.
    Wohlmuth, P.
    Gnant, M.
    Thaler, J.
    BRITISH JOURNAL OF CANCER, 2007, 97 (08) : 1021 - 1027
  • [48] Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer
    Aitelli, C. L.
    Kirkpatrick, H. M.
    Qin, H.
    Lichliter, W. E.
    Becerra, C. R.
    McCollum, A. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [49] Discovery and validation of a 10-gene predictive signature for response to adjuvant chemotherapy in stage II and III colon cancer
    Xu, Chaohan
    Xia, Peng
    Li, Jie
    Lewis, Keeli. B.
    Ciombor, Kristen K.
    Wang, Lily
    Smith, J. Joshua
    Beauchamp, R. Daniel
    Chen, X. Steven
    CELL REPORTS MEDICINE, 2024, 5 (08)
  • [50] Adjuvant Chemotherapy Is Associated With Improved Survival in Patients With Stage II Colon Cancer
    Casadaban, Leigh
    Rauscher, Garth
    Aklilu, Mebea
    Villenes, Dana
    Freels, Sally
    Maker, Ajay V.
    CANCER, 2016, 122 (21) : 3277 - 3287
12345